Growth Metrics

Vanda Pharmaceuticals (VNDA) EPS (Basic) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 139.68%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.58%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.28%
7 Evaxion A 62.56 Bn 62.54 Bn - 58.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.92%
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -150.22%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -150.22%
Dec 31, 2025 -179.85%
Sep 30, 2025 -102.74%
Jun 30, 2025 -123.74%
Mar 31, 2025 -65.65%
Dec 31, 2024 -39.12%
Sep 30, 2024 -38.26%
Jun 30, 2024 -35.19%
Mar 31, 2024 -34.58%
Dec 31, 2023 -32.64%
Sep 30, 2023 -72.10%
Jun 30, 2023 -42.76%
Mar 31, 2023 81.71%
Dec 31, 2022 14.47%
Sep 30, 2022 -68.28%
Jun 30, 2022 -38.97%
Mar 31, 2022 -122.40%
Dec 31, 2021 -13.38%
Sep 30, 2021 0.00%
Jun 30, 2021 23.61%
Mar 31, 2021 31.73%
Dec 31, 2020 79.15%
Sep 30, 2020 45.81%
Jun 30, 2020 94.28%
Mar 31, 2020 27.22%
Dec 31, 2019 115.44%
Sep 30, 2019 474.89%
Jun 30, 2019 58.74%
Mar 31, 2019 67.45%
Dec 31, 2018 37.30%
Sep 30, 2018 38.14%
Jun 30, 2018 39.12%
Mar 31, 2018 31.84%
Dec 31, 2017 -26.44%
Sep 30, 2017 -35.72%
Jun 30, 2017 63.94%
Mar 31, 2017 40.08%
Dec 31, 2016 64.84%
Sep 30, 2016 61.11%
Jun 30, 2016 2.86%
Mar 31, 2016 -21.92%
Dec 31, 2015 -13.92%
Sep 30, 2015 -5.01%
Jun 30, 2015 22.57%
Mar 31, 2015 5.01%
Dec 31, 2014 124.07%
Sep 30, 2014 28.62%
Jun 30, 2014 -133.92%
Mar 31, 2014 -448.74%
Dec 31, 2013 -69.56%
Sep 30, 2013 -52.48%
Jun 30, 2013 -63.86%